Nanoparticles of Melatonin and Lactoferrin for Improved Drug Delivery and Targeting Tumors in Cancer Treatment.

This review assesses the promise of nanoparticles containing melatonin and lactoferrin (ML-Lf-NPs) in treating cancer, concentrating on their capacity to improve drug delivery, pinpoint tumors, and optimize therapeutic efficacy. A thorough examination of recent progress in nanoparticle-oriented drug delivery systems was performed, highlighting the physicochemical characteristics, mechanisms of action, and biological interactions of ML-Lf-NPs. Melatonin nanoparticles demonstrate antioxidant and anti-inflammatory characteristics that enhance tumor targeting and therapeutic results. Lactoferrin nanoparticles show potential anticancer effects by improving cellular absorption and enabling targeted drug release at tumors. Both systems demonstrate considerable promise for enhancing drug bioavailability and minimizing side effects. ML-Lf-NPs signify creative strategies for cancer treatment. Their distinct characteristics allow for precise delivery and improved therapeutic effectiveness, opening doors for future clinical uses in cancer treatment. [Figure: see text].

• Publication year

  2025

• Venue

  Cancer Biotherapy and Radiopharmaceuticals

• Publication date

  2025-11-10

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1177/10849785251392733PMID 41212095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• QbD- Driven Development and Characterization of Lactoferrin-Loaded Nanoparticles in In-Situ Gel for Treating Postmenopausal Osteoporosis

  2025cited by this paper
• A pioneer review on lactoferrin as versatile macromolecular ligand for targeting cancer: recent advances

  2025cited by this paper
• Natural macromolecules polysaccharide-based drug delivery systems targeting tumor necrosis factor alpha receptor for the treatment of cancer: A review.

  2025cited by this paper
• Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles

  2025cited by this paper
• Fabrication of fucoxanthin-loaded composite nanoparticles based on lactoferrin and carboxymethyl chitosan: Interaction mechanism, stability and the application in filled hydrogel beads.

  2025cited by this paper
• Targeted and intelligent nano-drug delivery systems for colorectal cancer treatment

  2025cited by this paper
• Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy

  2025cited by this paper
• Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy

  2025cited by this paper
• Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer

  2025cited by this paper
• Anticancer potential of lactoferrin: effects, drug synergy and molecular interactions

  2025cited by this paper
• Protective Effects and Mechanisms of Lactoferrin and HIF-1α on Dry Eye Syndrome in Mice.

  2025cited by this paper
• Nanoparticle Formulations for Intracellular Delivery in Colorectal Cancer Therapy

  2025cited by this paper
• NGR‐Modified CAF‐Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma

  2025cited by this paper
• Lactoferrin conjugated radicicol nanoparticles enhanced drug delivery and cytotoxicity in prostate cancer cells.

  2025cited by this paper
• Lactoferrin Alone Vs Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia During The 3rd Trimester of Pregnancy (Randomized Controlled Trial)

  2025cited by this paper
• Tumor Cell-Targeting and Tumor Microenvironment–Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic/Photothermal/Chemodynamic Treatment of Cervical Cancer

  2024cited by this paper
• Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect

  2024cited by this paper
• Fabrication of lactoferrin-chitosan-etoposide nanoparticles with melatonin via carbodiimide coupling: In-vitro & in-vivo evaluation for colon cancer.

  2024cited by this paper
• Advancements in colorectal cancer treatment: The role of metal-based and inorganic nanoparticles in modern therapeutic approaches.

  2024cited by this paper
• Hyaluronic acid-functionalized carboxymethyl dextran-coated melatonin nanoconjugates for targeted etoposide delivery in metastatic colon cancer: Extensive in-vitro investigation in HCT116 cell lines, antimicrobial efficacy, and anti-angiogenic potential in chick chorioallantoic membrane (CAM) assay.

  2024cited by this paper
• Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma.

  2024cited by this paper
• Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications.

  2024cited by this paper
• Engineering Thermo/pH-Responsive Lactoferrin Nanostructured Microbeads for Oral Targeting of Colorectal Cancer.

  2024cited by this paper
• Understanding the journey of biopolymeric nanoformulations for oral drug delivery: Conventional to advanced treatment approaches

  2024cited by this paper
• The evaluation of melatonin and EGF interaction on breast cancer metastasis

  2024cited by this paper
• Co-STARs combine the advantages of chimeric antigen and T-cell receptors for the treatment of tumors with low antigen densities

  2024cited by this paper
• Receptor-Targeted Nanomedicine for Cancer Therapy

  2024cited by this paper
• Design, Synthesis, and Investigation of Anticancer and Antioxidant Potential of Novel Indole‐Based Melatonin Analogues in Breast Cancer

  2024cited by this paper
• Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles.

  2024cited by this paper
• Tailored Design of pH-Responsive Microbeads for Oral Delivery of Lactoferrin Nanotherapeutics of Colon Cancer

  2024cited by this paper
• pH-Sensitive Degradable Poly(ortho ester)-Polyesters As Injectable Viscous Fluid for Long-Acting Rheumatoid Arthritis Treatment

  2024cited by this paper
• PLGA-based nanocarrier for combined delivery of colchicine and purpurin 18 in cancer therapy: Multimodal approach employing cancer cell spheroids.

  2024cited by this paper
• The Impact of Cancer Stem Cells in Colorectal Cancer

  2024cited by this paper
• Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles

  2024cited by this paper
• Iron-saturated bovine lactoferrin: a promising chemopreventive agent for hepatocellular carcinoma.

  2024cited by this paper
• The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy

  2024cited by this paper
• Silver nanoparticle functionalized by glutamine and conjugated with thiosemicarbazide induces apoptosis in colon cancer cell line

  2024cited by this paper
• Melatonin-Loaded Nanoparticles Augment Mitophagy to Retard Parkinson's Disease.

  2024cited by this paper
• Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design.

  2024cited by this paper
• Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies

  2024cited by this paper
• Development of mesoporous silica-based nanoparticles for cancer phototherapy

  2024cited by this paper
• Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder.

  2023cited by this paper
• Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application

  2023cited by this paper
• Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings

  2023cited by this paper
• Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle

  2023cited by this paper
• Therapeutic potential of lactoferrin-coated iron oxide nanospheres for targeted hyperthermia in gastric cancer

  2023cited by this paper
• Regulation of HeLa cell proliferation and apoptosis by bovine lactoferrin

  2023cited by this paper
• Melatonin protects mice from 5-FU hepatotoxicity and improves 5-FU antitumor effects by an apoptotic pathway dependent on cell cycle arrest in A549 human lung cancer cells

  2023cited by this paper
• Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

  2023cited by this paper
• Green synthesis, characterization of melatonin-like drug bioconjugated CoS quantum dots and its antiproliferative effect on different cancer cells

  2023cited by this paper
• Green synthesis, characterization, anti-SARS-CoV-2 entry, and replication of lactoferrin-coated zinc nanoparticles with halting lung fibrosis induced in adult male albino rats

  2023cited by this paper
• Melatonin delivered in solid lipid nanoparticles ameliorated its neuroprotective effects in cerebral ischemia

  2023cited by this paper
• Advancing translational research for colorectal immuno-oncology

  2023cited by this paper
• Fucoidan/chitosan layered PLGA nanoparticles with melatonin loading for inducing intestinal absorption and addressing triple-negative breast cancer progression.

  2023cited by this paper
• Lipid nanoparticles for siRNA delivery in cancer treatment.

  2023cited by this paper
• Suppression of VEGF and inflammatory cytokines, modulation of Annexin A1 and organ functions by galloylquinic acids in breast cancer model

  2023cited by this paper
• Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats

  2023cited by this paper
• Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models

  2023cited by this paper
• Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy.

  2023cited by this paper
• RETRACTED ARTICLE: Anticancer activity of lactoferrin-coated biosynthesized selenium nanoparticles for combating different human cancer cells via mediating apoptotic effects

  2023cited by this paper
• Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System

  2023cited by this paper
• Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin.

  2023cited by this paper
• A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults

  2023cited by this paper
• Engineered Microencapsulated Lactoferrin Nanoconjugates for Oral Targeted Treatment of Colon Cancer.

  2023cited by this paper
• Melatonin as a Promising Agent for Cancer Treatment: Insights into its Effects on the Wnt/beta-catenin Signaling Pathway.

  2023cited by this paper
• Pharmacokinetics and tumor delivery of nanoparticles.

  2023cited by this paper
• Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer

  2023cited by this paper
• Melatonin modulates the Warburg effect and alters the morphology of hepatocellular carcinoma cell line resulting in reduced viability and migratory potential.

  2023cited by this paper
• Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy

  2023cited by this paper
• Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1

  2023cited by this paper
• Quantitative Comparison of Gold Nanoparticle Delivery via the Enhanced Permeation and Retention (EPR) Effect and Mesenchymal Stem Cell (MSC)-Based Targeting.

  2023cited by this paper
• Regulation and functions of cell division in the intestinal tissue.

  2023cited by this paper
• Nanoparticle Drug Delivery Systems and Their Applications as Targeted Therapies for Triple Negative Breast Cancer

  2023cited by this paper
• Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations

  2023cited by this paper
• An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment

  2022cited by this paper
• RNAi-based therapeutics and tumor targeted delivery in cancer.

  2022cited by this paper
• Nanotechnology-based advances in the efficient delivery of melatonin

  2022cited by this paper
• Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways

  2022cited by this paper
• Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer

  2022cited by this paper
• Current Surgical Management Strategies for Colorectal Cancer Liver Metastases

  2022cited by this paper
• The potential anti-cancer effects of melatonin on breast cancer

  2022cited by this paper
• Melatonin decreases androgen-sensitive prostate cancer growth by suppressing SENP1 expression

  2022cited by this paper
• Application of Nanotechnology in Combinatorial Immunotherapy-Based Cancer Treatment Approach.

  2022cited by this paper
• Nanoparticles: From synthesis to applications and beyond.

  2022cited by this paper
• Use of Melatonin in Cancer Treatment: Where Are We?

  2022cited by this paper
• Colon targeted chitosan-melatonin nanotherapy for preclinical Inflammatory Bowel Disease.

  2022cited by this paper
• Recent Estimates and Predictions of 5-Year Survival in Patients with Gastric Cancer: A Model-Based Period Analysis

  2022cited by this paper
• Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment

  2022cited by this paper
• The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy

  2022cited by this paper
• Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update

  2022cited by this paper
• Nanoparticle-based medicines in clinical cancer therapy

  2022cited by this paper
• Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect

  2022cited by this paper
• Melatonin has an inhibitory effect on MCF‐7 and MDA‐MB‐231 human breast cancer cell lines by inducing autophagy and apoptosis

  2022cited by this paper
• Role of oxidative stress in angiogenesis and the therapeutic potential of antioxidants in breast cancer.

  2022cited by this paper
• Augmenting apoptosis-mediated anticancer activity of lactoperoxidase and lactoferrin by nanocombination with copper and iron hybrid nanometals

  2022cited by this paper
• Anticancer properties of melatonin and its role as an adjuvant in cancer treatment

  2022cited by this paper
• Melatonin: Potential avenue for treating iron overload disorders

  2022cited by this paper
• FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer

  2022cited by this paper
• Therapeutic efficacy of Nano-formulation of lactoperoxidase and lactoferrin via promoting immunomodulatory and apoptotic effects.

  2022cited by this paper
• Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy.

  2022cited by this paper

• Liver targeted nanomedicine for treatment of fibrosis and hepatocellular carcinoma: Emerging strategies in ligand-guided, stimuli-responsive and gene-based delivery

  2026cites this paper